4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-19-047571
Chief Legal Officer sold 3,264 shares at an average $100.05 ($326,555)
- Chief Legal Officer acquired 3,264 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lippoldt Darin · Chief Legal Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-23 | Exercise or conversion : show line 1 in the form | +1,664 | $32.99 | $54,895 | 21,625 | D |
| 2019-08-23 | Sale : show line 2 in the form | −1,664 | $100.09 | $166,555 | 19,961 | D |
| 2019-08-27 | Exercise or conversion : show line 3 in the form | +1,600 | $32.99 | $52,784 | 21,561 | D |
| 2019-08-27 | Sale : show line 4 in the form | −1,600 | $100.00 | $160,000 | 19,961 | D |
| Open-market sales · 3,264 sh · avg $100.05 · $326,555 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2019-08-23 | Exercise or conversion : show line 5 in the form Non-Qualified Stock Option | −1,664 | $32.99 | $54,895 | $32.99 | 2025-02-03 | 1,664 | 14,961 | D |
| 2019-08-27 | Exercise or conversion : show line 6 in the form Non-Qualified Stock Option | −1,600 | $32.99 | $52,784 | $32.99 | 2025-02-03 | 1,600 | 13,361 | D |
Loading xslF345X03/doc4.xml…